SK

Suraj Kumar Singh

Active Director Director DIN 10976942
DIN 10976942 First appointment Feb 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Suraj Kumar Singh

Data last updated:

Suraj Kumar Singh is a Director at Gbs Health Care Private Limited (since 2025). The company operates in Healthcare.

DIN 10976942
Primary Designation Director
Industry Healthcare
First Appointment 28 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gbs Health Care Private Limited U86100UP2025PTC217905
Director28 Feb 20252025Active

Board colleagues of Suraj Kumar Singh

NameDINCompanyDesignation
Asif Kalam10976941Gbs Health Care Private LimitedDirector
Jasdeep Kaur10976943Gbs Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gbs Health Care Private Limited
Premium access

Shareholding and investment profile for Suraj Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suraj Kumar Singh

Suraj Kumar Singh currently holds 1 directorship: Gbs Health Care Private Limited (Director, since 28 Feb 2025).

Suraj Kumar Singh was first appointed on 28 Feb 2025 as Director at Gbs Health Care Private Limited.

The current boards of Suraj Kumar Singh's companies include Asif Kalam (Gbs Health Care Private Limited), Jasdeep Kaur (Gbs Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available